Eli Lilly, Shanghai firm to develop cancer drugs (The Wall Street Journal Europe, 21 Aug 2007, Page 7)

Eli Lilly, Shanghai firm to develop cancer drugs
By Jane Spencer
The Wall Street Journal Europe
21 Aug 2007

HONG KONG—A drug-development partnership between Eli Lilly & Co. of the U.S. and a Shanghai pharmaceuticals company reflects China’s growing potential as a lowcost center for biotechnology research. Yesterday, Indianapolis-based Lilly announced it... read more...

Tech Tags: The Wall Street Journal Europe newspaper Global Business Briefs